Medical Doctor Program year 2025 Reported 2022–2025 Source: CMS Open Payments, 2026 publication

Anthony D'andrea

Colon & Rectal Surgery Galveston, TX Medical Doctor

NPI 1497149637 CMS profile 11396441

1005 Harborside Dr 5Th Floor, Dept 710, Galveston, TX 77555

Open in the dashboard

General payments

$10,081

29 records reported · program years 2022–2025

Research payments

$0

Paid to them · None reported · program years 2022–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Anthony D'andrea of Galveston, TX is reported in the CMS Open Payments database as having received $10,081 across 29 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 77th percentile of Colon & Rectal Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $259 2
2024 General $1,153 8
2023 General $7,088 14
2022 General $1,581 5

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Anthony D'andrea
  • Colon & Rectal Surgery median
  • Middle half of Colon & Rectal Surgery
  • National median

In program year 2025, general payments to Anthony D'andrea were reported at $259. Among 1,481 Colon & Rectal Surgery profiles paid that year, the median was $317 and the middle half received between $109 and $1,248.

Show as a table
Year Anthony D'andrea Colon & Rectal Surgery median Middle half National median
2019 $0 $443 $125–$2,179 $163
2020 $0 $167 $53–$931 $114
2021 $0 $207 $72–$1,272 $132
2022 $1,581 $341 $111–$1,587 $149
2023 $7,088 $322 $115–$1,420 $160
2024 $1,153 $328 $112–$1,354 $164
2025 $259 $317 $109–$1,248 $169

Breakdown

Who paid General payments · program years 2022–2025
  1. Intuitive Surgical, Inc. $8,857 18 payments
  2. Stryker Corporation $559 4 payments
  3. FUJIFILM Medical Systems USA, Inc. $305 2 payments
  4. THD America, Inc. $136 1 payment
  5. Hollister Incorporated $115 1 payment
  6. Solventum Corporation $44 1 payment
  7. Monaghan Medical Corporation $38 1 payment
  8. Northgate Technologies, Inc. $28 1 payment

Every payment, record by record

What the payments were for General payments · program years 2022–2025
  1. Education $6,500 3 payments
  2. Travel and Lodging $2,343 12 payments
  3. Food and Beverage $1,229 13 payments
  4. Gift $9 1 payment
Products named General payments · program years 2022–2025
  1. DAVINCI XI $6,500 3 payments
  2. Da Vinci Surgical System $2,357 15 payments
  3. 1788 $457 3 payments
  4. FUJIFILM $305 2 payments
  5. New Image $115 1 payment
  6. SPY-PHI SYSTEM $102 1 payment
  7. PREVENA $44 1 payment
  8. V.A.C.INSTILL $44 1 payment
  9. AeroChamber $38 1 payment
  10. Stimsite (NTI) $28 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 3 drugs

Part D claims

61

Median for General Surgery: 59

Drug cost

$568

Median for General Surgery: $393

Branded share of claims

42.6%

Median for General Surgery: 28.9%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl Brand 26 $434
Neomycin Sulfate Generic 15 $81
Metronidazole Generic 20 $53

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 15,891 Part D prescribers listed as General Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 36 billing codes

Paid by Medicare

$18,209

Medicare's payments for the services billed

Medicare patients

83

Average age 72

Services billed

185

34 women, 49 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 43%
Ischemic heart disease 37%
Diabetes 31%
Cancer 29%
Chronic kidney disease 24%
Heart failure 22%
Depression 20%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

29 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Colon & Rectal Surgery in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record